26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

264<br />

Chapter | 9 Iron Metabolism and Its Disorders<br />

In contrast, only about 3% <strong>of</strong> the iron in plasma results<br />

from enterocyte absorption in normal individuals ( Ponka et<br />

al ., 1998 ).<br />

V. REGULATION OF IRON METABOLISM<br />

A. Intracellular Regulation <strong>of</strong><br />

Iron Metabolism<br />

1 . Cytoplasmic Regulation <strong>of</strong> Iron<br />

The synthesis <strong>of</strong> a number <strong>of</strong> proteins important in iron<br />

metabolism, including apotransferrin, TfR1, ap<strong>of</strong>erritin,<br />

DMT1, DcytB, ferroportin, iron responsive protein-1 (IRP1),<br />

and erythroid-specific 5-aminolevulinic acid synthase (eALAS<br />

or ALAS2), is regulated posttranscriptionally depending on<br />

intracellular iron content ( Beutler, 2006b ; Koury and Ponka,<br />

2004 ; Latunde-Dada et al ., 2006a ). The mRNA for each protein<br />

contains one or more iron responsive elements (IREs),<br />

each consisting <strong>of</strong> a stem-loop structure. The IREs located at<br />

the 5 end <strong>of</strong> mRNAs regulate translation, and IREs located<br />

at the 3 end regulate mRNA stability. IRP1 contains an<br />

Fe-S (4Fe-4S) cluster and exhibits aconitase activity when<br />

cells are iron replete, but it lacks the Fe-S cluster and aconitase<br />

activity when cytoplasmic iron is scarce. IRP1 binds<br />

tightly to IREs when cytoplasmic iron content is low. IRP2<br />

is closely related to IRP1, but it lacks aconitase activity. The<br />

regulation <strong>of</strong> IRP2 is mediated by proteosomal degradation<br />

when cellular iron is adequate, through binding to iron and<br />

possibly heme ( Wingert et al ., 2005 ). The binding <strong>of</strong> IRPs<br />

to IREs at the 5 end <strong>of</strong> mRNAs (including ap<strong>of</strong>erritin and<br />

eALAS) inhibits translation and protein synthesis from these<br />

mRNAs, but the binding <strong>of</strong> IRPs to IREs at the 3 end <strong>of</strong><br />

mRNAs (including TfR1 and intestinal DMT1) promotes<br />

mRNA stability, thereby enhancing protein synthesis from<br />

these mRNAs. When cytoplasmic iron content is high, IRPs<br />

are displaced from IREs, resulting in opposite effects on<br />

protein synthesis ( Starzynski et al ., 2004 ). Because <strong>of</strong> these<br />

controlling factors, TfR1 synthesis is higher and ap<strong>of</strong>erritin<br />

synthesis is lower when cytoplasmic iron content is low, and<br />

TfR1 synthesis is lower and ap<strong>of</strong>erritin synthesis is higher<br />

when cytoplasmic iron content is high ( Napier et al ., 2005 ).<br />

2 . Mitochondrial Iron Metabolism and<br />

Regulation<br />

Mitochondria are clearly central in the intracellular metabolism<br />

<strong>of</strong> iron; however, much remains to be discovered<br />

about their iron metabolism. The first enzyme reaction in<br />

heme synthesis (ALAS) and the final three enzyme reactions<br />

(including the insertion <strong>of</strong> Fe 2 into protoporphyrin<br />

IX by ferrochelatase to form heme) occur within mitochondria<br />

(see Chapter 8 for details), and proteins involved in<br />

Fe-S cluster synthesis are located within mitochondria.<br />

Fe-S cluster synthesis has been studied in microbes, but<br />

this pathway has not been well characterized in mammals.<br />

An inherited defect in a small protein called frataxin causes<br />

Friedreich ataxia in humans ( Napier et al ., 2005 ). This<br />

disorder results in spino/cerebellar ataxia, cardiomyopathy,<br />

and diabetes associated with mitochondrial iron overload<br />

in nerve and cardiac tissue, but not in erythroid cells.<br />

Frataxin participates in the synthesis <strong>of</strong> Fe-S clusters, possibly<br />

as a mitochondrial iron chaperone that shields this<br />

metal from reactive oxygen species and renders it bioavailable<br />

as Fe 2 (Napier et al ., 2005 ). Heme and Fe-S clusters<br />

synthesized within mitochondria are used locally and<br />

exported from mitochondria for insertion into cytoplasmic<br />

and nuclear enzymes. With the exception <strong>of</strong> a limited number<br />

<strong>of</strong> enzymes, such a ribonucleotide reductase, that have<br />

mono- or di-iron-binding sites, iron in heme and Fe-S clusters<br />

accounts for most <strong>of</strong> the enzyme iron. Consequently,<br />

almost all <strong>of</strong> the iron within cells must transit through mitochondria<br />

to be functionally active ( Arosio and Levi, 2002 ).<br />

Mit<strong>of</strong>errin, a member <strong>of</strong> the vertebrate mitochondrial<br />

solute carrier family (SLC25), appears to be essential for<br />

the uptake <strong>of</strong> iron into mitochondria ( Shaw et al ., 2006 ).<br />

The transporter needed to export heme from mitochondria<br />

to the cytoplasm is unknown; however, an inner mitochondrial<br />

membrane ATP-binding cassette protein B7 (ABCB7)<br />

appears to be required as an exporter for Fe-S clusters<br />

(Napier et al ., 2005 ). Studies in a zebra fish shiraz model<br />

indicate that heme synthesis in erythroid cells is dependent<br />

on the production <strong>of</strong> Fe-S clusters ( Wingert et al ., 2005 ).<br />

Deficient Fe-S cluster formation (resulting from glutaredoxin<br />

5 deficiency) and the resultant deficiency <strong>of</strong> Fe-S clusters<br />

in the cytoplasm <strong>of</strong> developing erythroid cells result in<br />

IRP1 binding to IREs <strong>of</strong> eALAS and the inhibition eALAS<br />

translation. A deficiency in eALAS activity in zebra fish erythroid<br />

cells results in deficient heme synthesis and the formation<br />

<strong>of</strong> hypochromic erythrocytes ( Wingert et al ., 2005 ).<br />

A human with mitochondrial glutaredoxin 5 deficiency has<br />

recently been described with sideroblast-like microcytic anemia<br />

and iron overload ( Camaschella et al ., 2007 ).<br />

Mitochondria can store excess iron using mitochondrial<br />

ferritin (m-ferritin). Unlike cytoplasmic ap<strong>of</strong>erritin, mitochondrial<br />

ap<strong>of</strong>erritin lacks an IRE and may be transcriptionally<br />

regulated by iron. M-ferritin forms homopolymeric<br />

shells that have more homology with cytoplasmic H-ferritin<br />

chains than L-ferritin chains ( Napier et al ., 2005 ). M-ferritin<br />

concentration is very low in most cells, including erythroid<br />

cells, but it is markedly increased in disorders with mitochondrial<br />

iron overload, presumably limiting the oxidative<br />

damage generated by the excess iron. M-ferritin appears to<br />

be degraded to hemosiderin-like material within mitochondria,<br />

but the mechanism is unknown ( Napier et al ., 2005 ).<br />

B. Systemic Regulation <strong>of</strong> Iron Metabolism<br />

Hepcidin, a small antimicrobial peptide secreted by hepatocytes<br />

into the circulation, is an important regulator

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!